Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    Loans
    HomeNewsAjay bodke of prabhudas lilladher

    Ajay Bodke Of Prabhudas Lilladher

    Jump to

    • Here are Ajay Bodke's fundamental views on market

      Watch the interview of Ajay Bodke, CEO & Chief Portfolio Manager of Prabhudas Lilladher with Prashant Nair and Ekta Batra of CNBC-TV18. He shared his reading and outlook on the market and also gave recommendations on various stocks.

    • Here are Ajay Bodke's fundamental views on market

      Watch the interview of Ajay Bodke of Prabhudas Lilladher with Prashant Nair and Ekta Batra of CNBC-TV18. He shared his reading and outlook on the market and also gave recommendations on various stocks.

    • Stay away from Bharat Forge, Motherson Sumi: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher is of the view that one can stay away from Bharat Forge and Motherson Sumi and feels that YES Bank may test Rs 1200 in the next 12-18 months.

    • Prefer Dabur on dips; Maruti, Tata Motors top picks: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher prefers Dabur India on dips and has Maruti Suzuki and Tata Motors as top picks.

    • Petronet LNG top buy idea, target Rs 300: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher is of the view that Petronet LNG is the top buy idea with a target of Rs 300.

    • Positive on NIIT Tech; ACC, JK Lakshmi top picks: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher has a positive view on NIIT Tech and Maruti Suzuki and has ACC and JK Lakshmi Cement as the top picks from the cement space.

    • Positive on KEC International, HUL, Dabur, Britannia: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher has a positive view on KEC International, Hindustan Unilever, Dabur India and Britannia Industries.

    • Positive on Britannia, GSK Consumer: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher has a positive view on Britannia Industries and GlaxoSmithKline Consumer Healthcare.

    • Positive on Jubilant Life Sciences, Aurobindo Pharma: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher has a positive view on Jubilant Life Sciences and Aurobindo Pharma.

    • Positive on JK Lakshmi Cement, hold Infosys: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher has a positive view on JK Lakshmi Cement with a target of Rs 400 and advises holding Infosys.

    • Buy IndusInd Bank, HDFC Bank; see better Q4 numbers: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher is of the view that IndusInd Bank and HDFC Bank are the top buys from the private banking space and expects better Q4 numbers.

    • Prefer Ashok Leyland, GSK Cons, Sun Pharma: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher is of the view that one can look at Ashok Leyland, Tata Motors, GlaxoSmithKline Consumer Healthcare, Britannia Industries and Sun Pharma.

    • Likely 25 bps RBI rate cut; buy rate-sensitives: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher believes Nifty is set to see 7800-7900 levels in the short-term. Investors can continue with their longs, he adds.

    • Prefer Indian Oil Corporation, Petronet LNG: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher prefers Indian Oil Corporation and Petronet LNG from the oil & gas space.

    • Like Britannia Industries, GSK Cons may hit Rs 6940: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher likes Britannia Industries for a target of Rs 3200 and GlaxoSmithKline Consumer Healthcare with a target of Rs 6940.

    • Maruti Suzuki, Tata Motors top picks from auto space: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher is of the view that Maruti Suzuki and Tata Motors are the top picks from auto space.

    • Hexaware Technologies may test Rs 300 in medium term: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher is of the view that Hexaware Technologies may test Rs 300.

    • Prefer JSPL, JSW Steel, Tata Steel: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher is of the view that one may prefer JSPL, JSW Steel and Tata Steel.

    • Tata Motors looks attractive for medium term: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher is of the view that Tata Motors looks attractive for medium term.

    • Jubilant Life may hit Rs 578, see upside in Glenmark: Bodke

      Ajay Bodke of Prabhudas Lilladher is of the view that Jubilant Life Sciences may test Rs 578 and expects upside in Glenmark Pharma.

    • Positive on Infosys, target Rs 1,340 in medium term: Bodke

      Ajay Bodke of Prabhudas Lilladher has a positive view on Infosys and has a price target of Rs 1,340 in the medium term.

    • Positive on Sun Pharma, says Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher has a positive view on Sun Pharma.

    • Look at Axis Bank, YES Bank; focus on Maruti: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher is of the view that one can look at Axis Bank, YES Bank and ICICI Bank and focus on Maruti Suzuki and Tata Motors.

    • Bharat Forge strong buy, prefer Maruti Suzuki: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher is of the view that Bharat Forge is a strong buy and prefers Maruti Suzuki with a medium term view.

    • Look at Sadbhav Engineering, SBI, Shriram Trans: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher is of the view that one can look at Sadbhav Engineering, Ashoka Buildcon, Cummins India, State Bank of India, HDFC Bank and Shriram Transport Finance Corporation.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347